Brain STimulation for ANxiety and Depression in Youth
Recruiting · NCT06892847 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Calgary
View the official record on ClinicalTrials.gov →Interventions studied
Transcranial Magnetic Stimulation
What this trial is about
In this open-label trial, the overall aim is to determine if TMS treatment can improve anxiety and depression in a broad group of children and youth referred by physicians.
Who can take part
Age range
6 Years to 18 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- aged between 6 and 18 years old
- diagnosis of anxiety or depression made by a qualified medical professional
- active anxiety and/or depression symptoms
Exclusion criteria
- status epilepticus in past 12-months
- presence of any disease, medical condition, or physical condition that, in the opinion of the study investigator may compromise, interfere, limit, affect, or reduce the participant's ability to complete the study
- hospitalization for suicide attempt within the past 3 months (unless participant is under the daily supervision of a physician, such as in a mental health day treatment program)
- TMS-related contraindications, including implanted medical devices (e.g., pacemaker)
- if actively taking prescription medication, no changes in medication for at least 3 months prior to entry into the study, with no anticipation of change in the frequency or dose over the duration of the study, unless changes to medication are required for participant safety
- unable to understand instructions in English
Where it is running
1 location listed.
- Alberta Children's Hospital - Calgary, Alberta, Canada